Evidence map›Paper›PMID 35212993›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Chromatin Immunoprecipitation Assay in Primary Mouse Hepatocytes and Mouse Liver.

Simiao Xu, Yangyang Liu, Ji Miao

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Simiao XuDivision of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Branch of the National Clinical Research Center for Metabolic Disease, Wuhan, China.
Yangyang LiuDivision of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Ji MiaoDivision of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. ji.miao@childrens.harvard.edu.ORCID 0000-0003-0869-4492
Boston Children's Hospital · US

Funding

Role of TAZ in metabolic regulation in both normal and insulin resistant statesR01DK124328 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI MIAO, JI · 2021 to 2025
$2.2M
NIDDK NIH HHS R01 DK124328
6 · The paper itself

Abstract

Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease characterized by hepatosteatosis, liver cell injury, and inflammation. The pathogenesis of NASH involves dysregulated transcription of genes involved in critical processes in the liver, including metabolic homeostasis and inflammation. Chromatin immunoprecipitation (ChIP) utilizes antibody-mediated immunoprecipitation followed by the detection of associated DNA fragments via real-time PCR or high-throughput sequencing to quantitatively profile the interactions of proteins of interest with functional chromatin elements. Here, we present a detailed protocol to study the interactions of DNA and chromatin-associated proteins (e.g., transcription factors, co-activators, co-repressors, and chromatin modifiers) and modified histones (e.g., acetylated and methylated) in isolated primary mouse hepatocytes and mouse liver. The application of these methods can enable the identification of molecular mechanisms that underpin dysregulated hepatic processes in NASH.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsChromatinChromatin ImmunoprecipitationHepatocytesLiverMiceChromatinChromatin-associated proteinGene regulationHepatocytesHistone modificationMouse liverProtein–DNA interactionTranscription factor

Identifiers

PMID35212993
PMCPMC9642072
OpenAlexW4214643612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.